The Inflation Reduction Act in numbers: HHS predicts savings for more than 18 million people in 2025

New report estimates the Inflation Reduction Act will reduce out-of-pocket spending by nearly $7.4 billion annually for more than 18.7 million Medicare Part D enrollees in 2025.  Drug affordability continues to be under intense scrutiny in the US, with rising drug costs as well as high-cost specialty medicines resulting in many Medicare beneficiaries seeing growing out-of-pocket (OOP) costs. The Inflation Reduction Act (IRA), signed in August 2022, is tackling this problem head on and includes a number of provisions aimed at lowering prescription drug prices, expanding access to health insurance, and improving the quality of care.  Almost 51 million people...